ウェビナー動画：Hub Organoids + Genedata、オルガノイドモデリングとマルチオミクスデータを用いたがん治療薬プロジェクトのリスク軽減

本ウェビナーでは、HUB Organoids社Chief Scientific OfficerのSylvia F. Boj, Ph.D.氏とGenedata Principal Scientific ConsultantのDaniella Patton, Ph.D.が登壇し、医薬品開発におけるオルガノイド技術の革新的な応用方法と、適切な患者へ適切な治療をより早く提供するための実用的な科学的洞察を見出すプロセスの促進について紹介しています。

Get Insights On: 

• Establishing organoid co-cultures to model tumor and immune cell interaction in a dish
• Using organoids optimally to  develop various immunotherapy modalities including engineered T cells, CAR-T therapies, or therapeutics targeting the myeloid compartment
• Streamlining the integration of multimodal data derived from these experiments on a single digital platform
• Leveraging highly performant, self-service analysis and visualization tools to efficiently extract insights to advance precision medicine development

Who Should Watch? 

• Scientists conducting discovery, preclinical or clinical research seeking innovative disease models for exploration to develop precision medicine solutions
• Leaders in biopharma, biotech, or life sciences looking to accelerate clinical development
• Digitalization experts in pursuit of solutions to empower effective translational research and increase the value of R&D data